SELB Selecta Biosciences Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.

$4.14  -0.13 (-3.04%)
As of 10/18/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/22/2016
Outstanding shares:  115,079,292
Average volume:  715,824
Market cap:   $499,444,127
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    816212104
ISIN:        US8162121045
Valuation   (See tab for details)
PE ratio:   -10.87
PB ratio:   44.02
PS ratio:   10.56
Return on equity:   1,070.75%
Net income %:   -95.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy